What Is TIMP1? Function, Disease, and Clinical Use

TIMP1 is a protein your body makes to hold back the enzymes that cut up the scaffolding between cells. It turns out to do more than act as a brake, because it also signals to cells directly, which helps explain why it shows up in such different illnesses.¹ For most people the name matters because a raised blood level can be a warning sign, and one already built into a routine test for liver scarring.²

What TIMP1 Does in a Healthy Body

Between your cells sits a mesh of proteins, collagen among them. It gives tissue its shape. A family of enzymes called MMPs cuts this mesh so it can be repaired, reshaped, or cleared away. Left unchecked, those enzymes would keep cutting, so the body needs a brake, and the four TIMP proteins do that job.³ TIMP1 also blocks some related tissue-cutting enzymes beyond the MMPs.⁴

The braking is physical. TIMP1 has a wedge shape, and its long edge slides into the cutting groove of an MMP and plugs it.⁵ Each TIMP1 shuts down one enzyme at a time.⁶ It can also latch onto a different part of some MMPs without switching them off.⁷

Healthy tissue needs both cutting and braking, because too much and too little each cause trouble. This balance runs quietly in skin, liver, lungs, heart, and brain.

Since the scaffolding exists in nearly every tissue, its controllers do too. Wound healing, growth, and pregnancy all depend on reshaping tissue, which is why TIMP1 levels rise in so many different conditions.

The system is not all-or-nothing. TIMP1 is one of four TIMP proteins, so a shortage of one can sometimes be partly covered by the others. When the brake is too weak in a tissue, cutting enzymes can wear down scaffolding that should stay, which is why imbalance is studied in joint damage and in the weakening of blood vessel walls. When the brake is too strong, scaffolding that should be cleared stays put, the pattern seen in scarring.

TIMP1’s Second Job as a Cell Signal

Over evolution, the TIMP proteins picked up new partners on cell surfaces, including receptors. TIMP1 docks onto one called CD63 and turns on growth signals inside the cell.⁸ The tail end of TIMP1 is needed for this docking, and without it the signal fails.⁹ When TIMP1 binds CD63, the cell can change what it does, for example by growing, surviving, or making more collagen, even where no tissue-cutting enzymes are involved.

The effects can help or harm. In heart tissue cells, this signalling makes cells produce new collagen, feeding scarring.¹⁰ In the cells lining brain blood vessels, the same partnership helps keep the blood–brain barrier sealed.¹¹ In mice with brain injury or stroke, extra TIMP1 reduced brain damage.¹² Those protective results come mainly from mice and cell dishes. They suggest TIMP1 is part of the brain’s injury response, but no TIMP1 treatment for stroke or brain injury exists for people. TIMP1 is neither simply good nor bad; the effect depends on tissue and situation.¹³ Signalling through CD63 explains effects the brake role cannot, and it is why studies on TIMP1 often seem to contradict each other.

TIMP1 and Scarring in the Liver, Lungs, and Skin

Fibrosis is scarring, where collagen builds up faster than it is cleared. In a damaged liver, the cells that make scar release more TIMP1 and TIMP2.¹⁴ Breakdown of scar slows and it accumulates, which helps drive liver fibrosis.¹⁵ TIMP1 also draws immune cells into the liver, which worsens scarring in animal studies.¹⁶ And a stiffer, more scarred liver pushes these cells to release even more TIMP1.¹⁷ That makes a loop, which is why removing the original cause of damage matters: it is the main way to interrupt it early.

The liver is the clearest example. Long-term causes include fatty liver, alcohol, and hepatitis, and early scarring can often improve if the cause is removed. TIMP1 helps explain why scar persists once damage continues, which is why it became part of a liver blood test.

The lungs show a similar pattern. People with idiopathic pulmonary fibrosis, a scarring lung disease, have raised TIMP1 in their blood.¹⁸ But mice without TIMP1 still scar their lungs, so it is not the only driver.¹⁹

In skin, a keloid is a raised scar that grows beyond the original wound and is made of thick collagen bundles. In keloid scar cells, silencing TIMP1 led to that thick collagen being broken down.²⁰ The lab work suggests lowering TIMP1 lets the skin dismantle these bundles, but it is not an available treatment.

Why High TIMP1 Is a Concern in Cancer

Because it blocks tissue-cutting enzymes, TIMP1 was long expected to stop tumours spreading.²¹ Instead, higher TIMP1 has been linked to a worse outlook in many cancer types, including lung cancer.²² In tumours TIMP1 also acts as a signal that recruits support cells, vessels, and immune cells, and these effects can outweigh the brake role.

Tissue around prostate and colon tumours makes more TIMP1 than normal tissue, and it gathers support cells around the tumour that help it grow.²³ TIMP1 can also help tumours grow new blood vessels in lung cancer, though it needs the body’s main vessel-growth signal to do so.²⁴ Results on vessels conflict, though: some studies find TIMP1 slows vessel growth, others that it speeds it, and the form it is delivered in can change its effect. That conflict is one reason treatments are not yet ready.

TIMP1 may also act at a distance. In mice, high blood TIMP1 prepared the liver to receive spreading cancer cells by drawing in immune cells.²⁵ In kidney cancer, TIMP1 is linked to an immune environment that shields the tumour.²⁶

In colorectal cancer, about 76 in 100 people with low blood TIMP1 were alive at 5 years, compared with about 63 in 100 with high levels.²⁷ High blood TIMP1 still predicted shorter survival after accounting for cancer stage.²⁸

High TIMP1 is one factor among several, and it is not a routine test most cancer patients will be offered. If it appears in a report, your oncologist can tell you what it means for your case.

TIMP1 as a Blood Test for Liver Scarring

If you have TIMP1 measured, it is most likely as part of the ELF (Enhanced Liver Fibrosis) test. This blood test combines TIMP1 with two other scar markers.²⁹ It estimates how much scarring is in the liver without a biopsy, and it is commonly used in people with fatty liver disease to decide who needs further checks such as a liver scan. You will usually see one combined ELF score rather than a separate TIMP1 number. Each marker reflects a different part of scar formation and breakdown, and a formula combines the three into one score, so a single raised marker may not produce a high ELF score.

A low score suggests significant scarring is less likely. A higher score usually leads to a liver scan or specialist referral. The score is read alongside your other blood tests and history, and repeat testing can track change over time. The test sorts people by likely scarring level; it does not replace imaging or a biopsy when those are needed.

A TIMP1 level has limits. TIMP1 exists in the blood both free and attached to enzymes, which affects what a test measures.³⁰ Levels are also raised in inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis.³¹ So a high TIMP1 alone cannot say which organ or disease is involved.

If your ELF result is raised, useful questions include:

What does my score suggest about the stage of scarring?
Could another condition be raising the markers?
Should I have a scan to confirm?
What steps can help reduce liver damage?

TIMP1 in Arthritis and Bowel Disease

TIMP1 levels are raised in several inflammatory conditions; in one comparison³², people with inflammatory bowel disease had higher levels than those with ankylosing spondylitis, a spine arthritis.³³

Inflamed tissue is being damaged and rebuilt, and the body raises TIMP1 to control the cutting enzymes, so its level partly reflects how active the disease is. A high level points to a general inflammatory process rather than naming a condition.

There are hints it could track treatment. In rheumatoid arthritis on adalimumab, TIMP1 fell in people who responded and rose in those who did not.³⁴ It may one day help show whether a treatment is working, but that is still research.

For your care now, doctors track these diseases with standard tests and symptoms, and TIMP1 is not part of usual arthritis or bowel disease monitoring. A research blood test may include it in trials.

TIMP1 Outside Disease, Pregnancy and Infection

Ovulation needs the matrix-cutting enzymes to work.³⁵ For an egg to be released, the wall of the ovary follicle must thin and open, and those enzymes loosen the tissue. In rats, excess TIMP1 meant fewer eggs and poorer embryo development, and blocking it in a model of endometriosis restored fertility.³⁶

TIMP1 can also act far from where it is made. In mice, a lingering urinary tract infection raised blood TIMP1 and changed breast tissue, which blocking TIMP1 reversed.³⁷ Both findings come from rats and mice, and no test or treatment for people is based on them yet.

Treatments That Target TIMP1

Three strategies are being explored. Researchers have built fully human antibodies that strongly block TIMP1, as candidates to treat scarring.³⁸ Silencing the TIMP1 gene, which lowers how much protein cells make, eased lung injury and inflammation in mice.³⁹

Engineered TIMP1 goes the other way, using the protein as a medicine. It has been designed to block one enzyme while sparing a near-identical one.⁴⁰ A system that releases TIMP1 where wound enzymes are high is being developed to help diabetic wounds heal.⁴¹ Because TIMP1 helps some tissues and harms others, blocking it everywhere could cause problems.

Most results so far come from cells and animals, and human trials are needed before any use. None of these approaches is approved.

For now, the practical steps are to treat the underlying cause of scarring, such as alcohol use or fatty liver. If you have a fibrotic disease, you can ask about clinical trials. Be wary of supplements claiming to change TIMP1.